Malaria Vaccine Technology Roadmap update includes new targets
Read more »

Training and retaining young African scientists

By Dr. Margaret Gyapong, Director, Research Institution for Infectious Diseases of Poverty, based in Ghana
Read more »

Lab

Photo courtesy of PATH

Partnering with us

PuzzleWe are pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners.

Our portfolio

MVI portfolioWe maintain a diverse portfolio of projects, including preclinical feasibility studies, translational projects, and one advanced clinical project.

View the portfolio »

What we do and how we do it

MVI overview imageWe identify potentially promising malaria vaccine approaches and systematically move them through the development process. At the same time, we work to catalyze access to a successful malaria vaccine in the countries that need it most.

Read more »


World Malaria Day 2014 logo

news and announcements button

 

World Malaria Report shows decline in malaria illness and death

More than 3 million lives saved since 2000, but universal access to prevention and treatment still a long way off, says 2013 report.

 

Rise in R&D funding could set stage for malaria eradication

Report hails recent progress in reducing malaria illnesses and deaths, but warns new tools are needed to fight parasite resistance.

 

Global Health Innovative Technology Fund awards US$600,000 to PATH for its Malaria Vaccine Initiative

Investment will go toward identifying novel targets of immunity and accelerate the development of malaria vaccines to support elimination and eradication.

 

PATH Malaria Vaccine Initiative names new director

Ashley Birkett, PhD, to lead key product development program at PATH.

 

Results from ongoing Phase 3 clinical trial announced

Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children.

 

Events and conferences

Malaria 2014: Advances in Pathophysiology, Biology and Drug Development
April 25, 2014